Starling Oncology has launched Starling Nexus™, a new technology platform designed to optimize oncology provider engagement and accelerate high-quality care at scale. This platform aims to streamline the process for treatment authorization.

Benzinga has released a stock analysis report for Starling Oncology (STLN), covering its ratings, financials, and overall performance.